# DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM
> **ANDA214201** · Abbreviated New Drug Application (Generic) · Sponsor: ANDA REPOSITORY · Approved 2022-06-27
## Drug
- **FDA Application Number:** ANDA214201
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM
- **Generic name:** DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM
- **Active ingredients:** DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM
- **Dosage form:** SOLUTION
- **Route:** ORAL, RECTAL
- **Marketing status:** Prescription
- **Sponsor:** ANDA REPOSITORY
- **Manufacturer:** Guardian Drug Company
- **First approval:** 2022-06-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214201)
---
*AI Analytics · CC0 1.0*